These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4212198)

  • 41. Brain to bottle time.
    Burt RA
    Proc R Soc Med; 1974 Jun; 67(7):584-6. PubMed ID: 4211842
    [No Abstract]   [Full Text] [Related]  

  • 42. The pharmacology and toxicology of midaflur.
    Clark R; Lynes TE; Price WA; Smith DH; Woodward JK; Marvel JP; Vernier VG
    Toxicol Appl Pharmacol; 1971 Apr; 18(4):917-43. PubMed ID: 5570243
    [No Abstract]   [Full Text] [Related]  

  • 43. A novel intravenous vehicle for preclinical cardiovascular screening of small molecule drug candidates in rat.
    Banfor PN; Gintant GA; Lipari JM; Zocharski PD
    J Pharmacol Toxicol Methods; 2016; 82():62-67. PubMed ID: 27432021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluotracen: a tricyclic compound with the combined properties of antidepressants and antipsychotics in animals.
    Fowler PJ; Zirkle CL; Macko E; Setler PE; Sarau HM; Misher A; Tedeschi DH
    Arzneimittelforschung; 1977; 27(8):1589-95. PubMed ID: 410422
    [No Abstract]   [Full Text] [Related]  

  • 45. Trichloroethylene.
    IARC Monogr Eval Carcinog Risk Chem Man; 1976; 11():263-76. PubMed ID: 825436
    [No Abstract]   [Full Text] [Related]  

  • 46. Preclinical toxicology protocols of the Laboratory of Toxicology.
    Prieur DJ; Young DM; Davis RD; Cooney DA; Guarino AM
    Natl Cancer Inst Monogr; 1977 Mar; (45):159-77. PubMed ID: 412104
    [No Abstract]   [Full Text] [Related]  

  • 47. In vitro species comparisons and metabolite identification.
    Dow P
    Curr Protoc Pharmacol; 2006 Oct; Chapter 7():Unit7.10. PubMed ID: 22294177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Some pharmacological consequences of species variation in rates of metabolism.
    Brodie BB; Reid WD
    Fed Proc; 1967; 26(4):1062-70. PubMed ID: 6028770
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacodynamic and toxicological studies of Kalanchoe integra stem.
    Varma RK; Garg BD; Ahmad A
    Mater Med Pol; 1986; 18(4):207-10. PubMed ID: 3613680
    [No Abstract]   [Full Text] [Related]  

  • 50. Species differences: the basis for and importance of comparative toxicology.
    Oehme FW
    Clin Toxicol; 1970 Mar; 3(1):5-10. PubMed ID: 5520391
    [No Abstract]   [Full Text] [Related]  

  • 51. SYNTHESIS AND MUSCLE RELAXANT PROPERTIES OF 3-AMINO-4-ARYLPYRAZOLES.
    ANDERSON EL; CASEY JE; GREENE LC; LAFFERTY JJ; REIFF HE
    J Med Chem; 1964 May; 7():259-68. PubMed ID: 14204957
    [No Abstract]   [Full Text] [Related]  

  • 52. The pharmacology of 2-(ethylamino)-2-(2-thienyl)-cyclohexanone-HCl (CI-634).
    Chen G; Ensor CR; Bohner B
    J Pharmacol Exp Ther; 1969 Jul; 168(1):171-9. PubMed ID: 4978323
    [No Abstract]   [Full Text] [Related]  

  • 53. 6-(5-NITRO-2-FURYL)-AS-TRIAZINE-3,5(2H,4H)-DIONE. A POTENTIAL URINARY TRACT ANTIBACTERIAL.
    HAYES K
    J Med Chem; 1964 Nov; 7():819-20. PubMed ID: 14262824
    [No Abstract]   [Full Text] [Related]  

  • 54. First-time-in-human dose selection: allometric thoughts and perspectives.
    Boxenbaum H; DiLea C
    J Clin Pharmacol; 1995 Oct; 35(10):957-66. PubMed ID: 8568013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of drug formulations using LD50 testing in mice.
    Sheth PR; Shah NH; Pool W
    J Pharm Sci; 1977 Nov; 66(11):1567-70. PubMed ID: 915733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparative and evolutionary pharmacology].
    Mikhel'son MIa
    Usp Fiziol Nauk; 1977; 8(3):3-27. PubMed ID: 19894
    [No Abstract]   [Full Text] [Related]  

  • 57. A search to predict potential for drug-induced cardiovascular toxicity.
    Hamlin RL
    Toxicol Pathol; 2006; 34(1):75-80. PubMed ID: 16507547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preclinical toxicologic evaluation of chromomycin A3 (NSC-58 514) in mice, dogs and monkeys.
    Fleischman RW; Schaeppi U; Heyman IA; Phelan RS; Rosenkrantz H; Ilievski V
    Toxicol Appl Pharmacol; 1974 Feb; 27(2):259-70. PubMed ID: 4212258
    [No Abstract]   [Full Text] [Related]  

  • 59. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. I.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1-401. PubMed ID: 14278901
    [No Abstract]   [Full Text] [Related]  

  • 60. Application of metabolic data to the evaluation of drugs. A report prepared by the committee on problems of drug safety of the drug research board, National Academy of Sciences-National Research Council.
    Clin Pharmacol Ther; 1969; 10(5):607-34. PubMed ID: 4980111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.